000 | 01877 a2200565 4500 | ||
---|---|---|---|
005 | 20250517101842.0 | ||
264 | 0 | _c20170606 | |
008 | 201706s 0 0 eng d | ||
022 | _a1502-7708 | ||
024 | 7 |
_a10.3109/00365521.2016.1169588 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSagatun, Liv | |
245 | 0 | 0 |
_aFollow-up of patients with ECL cell-derived tumours. _h[electronic resource] |
260 |
_bScandinavian journal of gastroenterology _cNov 2016 |
||
300 |
_a1398-405 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoid Tumor _xmortality |
650 | 0 | 4 |
_aChromogranin A _xblood |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aEnterochromaffin-like Cells _xpathology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aGastrectomy |
650 | 0 | 4 |
_aGastric Mucosa _xpathology |
650 | 0 | 4 |
_aGastrins _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNorway |
650 | 0 | 4 |
_aOctreotide _xtherapeutic use |
650 | 0 | 4 |
_aReceptor, Cholecystokinin B _xantagonists & inhibitors |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSomatostatin _xanalogs & derivatives |
650 | 0 | 4 |
_aStomach Neoplasms _xmortality |
650 | 0 | 4 | _aTertiary Care Centers |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aFossmark, Reidar | |
700 | 1 | _aJianu, Constantin S | |
700 | 1 | _aQvigstad, Gunnar | |
700 | 1 | _aNordrum, Ivar S | |
700 | 1 | _aMjønes, Patricia | |
700 | 1 | _aWaldum, Helge L | |
773 | 0 |
_tScandinavian journal of gastroenterology _gvol. 51 _gno. 11 _gp. 1398-405 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/00365521.2016.1169588 _zAvailable from publisher's website |
999 |
_c26130418 _d26130418 |